Evoke Pharma, Inc. (EVOK)

Evoke Pharma Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	12.62	13.6	4.74	9.84	9.14	8.07
Cash & Short-Term Investments	12.62	13.6	4.74	9.84	9.14	8.07
Cash Growth	30.11%	186.88%	-51.85%	7.64%	13.33%	42.46%
Receivables	2.51	2.42	0.67	0.62	0.3	0.02
Inventory	0.53	0.45	0.48	0.29	0.19	0.24
Prepaid Expenses	0.52	0.73	0.89	0.95	0.92	0.92
Other Current Assets	0.04	0.04	0.05	0.01	0.01	0.03
Total Current Assets	16.23	17.24	6.83	11.72	10.56	9.28
Property, Plant & Equipment	0.14	0.15	-	0.13	0.01	0.14
Long-Term Deferred Charges	-	0.12	0.24	-	-	-
Other Long-Term Assets	0.01	0.01	-	-	-	0.01
Total Assets	16.38	17.52	7.07	11.85	10.57	9.43
Accounts Payable	2.28	2.04	1.61	0.87	0.87	1.27
Accrued Expenses	2.81	3.18	2.94	0.59	0.52	1.02
Short-Term Debt	-	-	-	-	-	0.1
Current Portion of Long-Term Debt	5	5	5	-	-	-
Current Portion of Leases	0.06	0.06	-	0.13	0.01	0.14
Other Current Liabilities	0.3	0.1	0.1	0.07	-	5
Total Current Liabilities	10.45	10.38	9.65	1.65	1.41	7.54
Long-Term Debt	-	-	-	5	5	5
Long-Term Leases	0.08	0.1	-	-	-	-
Other Long-Term Liabilities	-	-	-	1.11	0.61	0.11
Total Liabilities	10.53	10.48	9.65	7.77	7.02	12.65
Common Stock	0	0	0	0	0	0
Additional Paid-In Capital	135.94	135.83	120.86	119.73	110.98	95.67
Retained Earnings	-130.1	-128.79	-123.44	-115.65	-107.42	-98.89
Shareholders' Equity	5.84	7.04	-2.58	4.08	3.56	-3.21
Total Liabilities & Equity	16.38	17.52	7.07	11.85	10.57	9.43
Total Debt	5.14	5.16	5	5.13	5.01	5.25
Net Cash (Debt)	7.48	8.44	-0.26	4.71	4.13	2.82
Net Cash Growth	59.04%	-	-	14.09%	46.38%	-48.91%
Net Cash Per Share	3.18	4.43	-0.94	18.00	18.49	15.95
Filing Date Shares Outstanding	2.02	2.02	0.71	0.28	0.23	0.22
Total Common Shares Outstanding	2.02	2.01	0.28	0.28	0.23	0.18
Working Capital	5.78	6.86	-2.82	10.07	9.15	1.75
Book Value Per Share	2.89	3.49	-9.26	14.66	15.68	-17.39
Tangible Book Value	5.84	7.04	-2.58	4.08	3.56	-3.21
Tangible Book Value Per Share	2.89	3.49	-9.26	14.66	15.68	-17.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q